Log In
Print this Print this

CSG-GPC3 (formerly KJgpc3-001)

  Manage Alerts
Collapse Summary General Information
Company CARsgen Therapeutics Co. Ltd.
DescriptionGlypican-3 (GPC3) directed CAR-T cell therapy
Molecular Target Glypican 3 (GPC3)
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today